Bleeding risk with AZD6140, a reversible P2Y12 receptor antagonist, vs. clopidogrel in patients undergoing coronary artery bypass grafting in the DISPERSE2 trial
| Image |  |
|---|---|
| Description | scientific article |
| Author/s |
author: Robert F. Storey Håkan Emanuelsson |
| Publication date | April 1, 2009 |
| Language | |
| Country of origin | |
| Wikipedia link | |
| Copyright status | |
| Missing/wrong data? | Edit Wikidata item |